Neuphoria Therapeutics Inc. (NEUP): Shares Outstanding

Annual figures by period end, from SEC filings.

5.41M
As of 2026-06-30
-84.6%
3-year compound annual growth
1.47B2023-06-30: 1.47B2024-06-30: 1.10M2025-06-30: 1.98M2026-06-30: 5.41M5.41M
2023-06-30 Shares Outstanding (shares) 2026-06-30
Period endedShares OutstandingChange YoYSource filing
2026-06-305.41M+173.5%2026-09-18, Balance as of period end
2025-06-301.98M+79.2%2026-09-18, Balance as of period end
2024-06-301.10M-99.9%2025-09-29, Balance as of period end
2023-06-301.47Bn/a2024-09-30, Balance as of period end